We report the effect of sample matrix and pH on quantification of porphynns by HPLC with fluonmetnc detection. For aqueous solutions of pH <2.5, HPLC peak heights of the porphyrins increased with decreasing pH, reaching a plateau at pH <1 .0. This loss of porphyrins from solutions with pH >1 .0 appeared to be due to a combination of microprecipitation and aggregation effects. No such "pH effect" was observed for urine samples supplemented with mixed-porphyrin standards. Addition of trace amounts of albumin to aqueous solutions also decreased these pH-related losses. These findings suggest a porphyrin-protein interaction that prevents microprecipitation and aggregation processes. We conclude that standard solutions of porphyrins for HPLC analysis should be prepared in a urine matrix. If aqueous solutions are used, then the pH must be adjusted to <1.0. Urine samples from normal individuals require only adjustment of pH to <2 before analysis; however, porphync unnes requiring dilution should be prepared with porphyrin-free urine diluent. Additionally, the fluorescence intensity and the emission or excitation spectra of porphyrins are also determined by their ionization state (6). Alterations in the sample pH or matrix may therefore directly affect the fluorescent signal detected.
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Various "high-performance" liquid-chromatographic (HPLC) techniques
for quantifying urinary porphyrins have been published in the last 10 years (e.g., [1] [2] [3] [4] . We recently developed a high-speed HPLC technique for urinary porphyrin analysis (5) , in which urine is acidified to pH 2.5-3.0, filtered, and injected directly into the HPLC. However, we encountered inconsistent results with this technique when urine samples from porphyric patients were serially diluted with hydrochloric acid before quantification.
Critical alterations
in sample pH or matrix as a result of dilution may affect porphyrin solubility. (10) , "about 2" (11), or 2-fl (12) , as well as direct injection of unpreserved urine (4) or of urine collected in sodium carbonate (13) . Of these approaches, one would expect maximum aqueous solubility when the porphyrins are in the dicationic form (pH <2) or carboxylate form (pH greater than -8).
Additionally, the fluorescence intensity and the emission or excitation spectra of porphyrins are also determined by their ionization state (6) . Alterations in the sample pH or matrix may therefore directly affect the fluorescent signal detected.
Many ofthe published HPLC methods do not adequately consider the complex porphyrin-ionization states outlined above. Here we report the results of our systematic investigation ofthe effect ofpH in the range 0.5-2.5 with regard to porphyrin: fluorescence emission and excitation peak maxima; fluorescence intensity changes with protonation; precipitation or aggregation; oxidation/reduction; and solubility effects attributable to the matrix or salt formation.
We also discuss optimal conditions for the quantification of porphyrins in urine by HPLC.
MaterIals and Methods
Reagents. All porphyrin standard solutions and other reagents were identical to those described previously (5) .
Additionally, hydrochloride salts of individual porphyrin carboxylic acids were obtained from Porphyrin Products, Logan, UT 84321.
Chromatographic conditions.
Chromatographic equipment and conditions are described in detail elsewhere (5) . In brief, the system consisted of a Perkin-Elmer Series 4
liquid chromatograph (Perkin-Elmer (Canada) Ltd., Montreal, Quebec, Canada) fitted with a 20-L loop injector and a Perkin-Elmer LS-4 flowthrough fluorescence spectrophotometer (excitation wavelength 365 nm, emission wavelength 624 nm). Results were reported as relative fluorescence, i.e., individual peak heights expressed as a percentage of the integer for maximum peak height observed for all samples run on that day. The analytical column was a 3cm x 0.43 cm (i.d.) cartridge column containing octadecylsilyl particles 3 m in diameter (Perkin-Elmer).
Porphy-
rims were eluted with a linear gradient of 0.1 molJL sodium phosphate buffer (pH 3.5) and methanol at a flow rate of 2.5 mL/min. The proportion of methanol was changed from 500 mL/L at injection to 950 mLIL in 2 mm, held there for 2 min, then returned to initial conditions in a 1-mm linear gradient.
Re-equilibration 
Sample preparation.
Mixed porphyrin standard stock solutions were prepared by dissolving the contents of the chromatographic marker standard (Porphyrin Products) in 150 L of6 moIJL HC1, then adding 9.85 mL ofwater. These commercial standards include a dicarboxylic acid porphyrim (mesoporphyrin), whereas urine contains no dicarboxylic-acid porphyrins. Working solutions containing each porphyrin at 100 nmol/L were prepared by volumetric dilution of the stock solution with dilute HC1 or NaOH to yield solutions with pH values of 0.5-2.5. To adjust the ionic strength of the solutions at pH 2.0 to that of the solution at pH 0.5, we added 1.0 mL of a 30.6 molJL solution of KCI to 9.0 mL of water that had been adjusted to pH 2.0.
Spectroscopy.
Absorption spectra
were obtained with a Model DU-7 spectrophotometer (Beckman Instruments, Brea, CA 92621). Fluorescence spectra were obtained by introducing the sample directly into the cell of the PerkinElmer LS-4 fluorimeter, uncoupled from the HPLC. Emission spectra were obtained with an excitation wavelength of 400 nm. Excitation spectra were generated with an emission wavelength of 624 nm. Arbitrary amounts of each porphyrin carboxylic acid (HC1 salt) were dissolved in 6 moIJL HC1, diluted 50-fold with water and then 10-fold with dilute HC1 of various concentrations to give a range of pH values between 0.5 and 2.0 and absorbance values of <2. Figure 1 illustrates the effect of sample pH on fluorescence peak height after HPLC separation of filtered porphyrin-standard solutions. The peak height increased for all porphyrins with decreasing pH. For the porphyrins found in urine, this effect appeared to plateau at pH <1.0.
Results and DiscussIon
Effect of pH on Fluorescence
Porphyrin fluorescence intensity, as well as emission and excitation peak maxima and minima, is affected by pH (6, 14) . Polo et al. (15) recently studied the factors influencing fluorescence spectra of free porphyrins and found that the wavelength maxima of the three main emission peaks vary in the pH range 1-11, and that ionic strength strongly affects fluorescence intensity. They did not speculate as to whether this resulted from solubility, oxidation/reduction, or ionization effects.
To investigate whether the results summarized in Figure  1 were ascribable to spectroscopic effects, we obtained the fluorescence spectra of solutions of individual porphyrins in dilute HC1. In the pH range 0.5-2.0, shifts in emission and excitation wavelength maxima were only minimal; fluorescence intensity decreased with increasing pH, but no new bands were observed. These spectroscopic effects cannot, however, account for the results shown in Figure 1 Bailey (12) reported that substantial lossesof coproporphyrim from urine are caused by co-precipitation with other materials in slightly acidic conditions. In contrast, Rossi and Curnow (16) suggested that urine must be acidified to dissolve any precipitated calcium salts, which can adsorb porphyrins.
In our study, no gross precipitate was visible in any of the solutions of PH 0.5-2.5. To investigate whether losses of porphyrins from solution of PH <2.5 were due to microprecipitation, we prepared mixed porphyrin standard solutions at various pH values, ifitered (0.45 pin pore size) and unfiltered, and injected samples ofeach into the HPLC. For solutions ofpH 0.45, <5% ofthe porphyrins are lost on the filters (Table 1 ). In contrast, 24.1-54.1% of porphyrins was retained for solutions of pH 2.24. Although these results may demonstrate a pH-dependent interaction of filter and porphyrin, our use of inert-fluorocarbon ifiters makes it more reasonable to assume that the losses occur through microprecipitation.
The apparent microprecipitation with subsequent loss on the filter does not completely account for the differences observed between solutions of pH 1 and those of pH 2, because substantial decreases in fluorescence are also seen for unfiltered solutions ( Table 2) . The effects observed in the unfiltered samples were less severe than those observed in the filtered solutions, suggesting that, although some porphyrins are lost during the filtration process, filtrable non-fluorescent porphyrin complexes may also be present in solutions of pH 1-2 that are not solubilized in the methanolic mobile phase.
In addition to macro-or microprecipitation, the analytical recovery of porphyrins from solution may also be decreased by aggregation and (or) dimerization.
Brown et al. (17) noted that protoporphyrin
and coproporphyrin aggregate in aqueous solution, resulting in a decrease of the absorptivity and a broadening of the Soret band. In dilute solutions, electrostatic interaction and stacking of parallel overlapping porphyrin rings results in dimerization, which is both pH-and temperature-dependent.
Redmond et al. (18) noted that aggregation of porphyrins in solution inhibits excitation to the triplet state and subsequently decreases the "fluorescent activity." They were able to monomerize several species of porphyrins with detergents and organic solvents (methanol or acetone). If porphyrin dimerization in solutions of pH <2 is contributing to the effect shown in Figure 1 , one would anticipate that the high methanol content of the HPLC mobile phase would also monomerize these species, unless porphyrin mixing with the mobile phase is not sufficient to promote disaggregation. The effect of pre-injection mixing of samples with methanol was evaluated by diluting mixed porphyrin standard solutions of pH 0.5, 1,5, and 2.0 with an equal volume either of water adjusted to equivalent pH or methanol. Figure 2 illustrates that, except for mesoporphyrin, direct mixing with methanol did indeed restore the fluorescence intensity of the filtered solutions at pH 1.5 and 2.0 to values equivalent to or greater than that at pH 0.5. A slight pH effect was still apparent, however. Each porphyrin 100 nmovL, in a mixture of standards.
For clinical analyses, dilution of samples with methanol before analysis is not practicable. Methyl esters of the porphyrins are rapidly formed on standing in acidic methanol, resulting in double peaks (carboxylic acids + methyl esters) in HPLC analysis. Furthermore, dilution of samples eliminates the major advantage of the originally published method: minimal sample preparation and the ability to detect low concentrations of porphyrins in urine samples. Any dilution exceeding 10% may prevent detection of some porphyrins at the upper limit of normal in urine. Concentration of samples would eliminate the simplicity and rapid turnaround time of the method.
Matrix Effects
Westerlund et al. (19) have suggested that poor analytical recovery and precision of porphyrin analyses may result from matrix effects and (or) incomplete oxidation of porphyrinogens to porphyrins in the urine samples before analysis. The latter proposal does not account for the effect illustrated in Figure 1 , because pH-dependent variability was observed for porphyrin standards that contained no porphyrinogens. Matrix effects due to differences in ionic strength have recently been shown to produce a "pH effect" on fluorescence (15). We used solutions of KC1 to ensure that all aqueous samples attained equivalent ionic strength, but this did not eliminate the pH-dependent effects over the pH range 0.5-2.0. However, as shown in (Table 3) failed to prevent the "pH effect." In the presence of albumin concentrations of 30 mg/L, -80% of added porphyrins was accounted for, compared with -50% when water was the solvent. We cannot define the nature of the urine or albumin matrix effects, but we 
